Christopher Fuller

2.2k citations
35 papers · 1.5k · h-index 21

Impact in

Papers in

Co-authors
Susan G. Michie (13 shared papers)Andrew C Hayward (15 shared papers)B. Cookson (8 shared papers)Peter E. Reynolds (2 shared papers)Ben Symons Cooper (7 shared papers)Richard Nelson Perham (7 shared papers)Sheldon Stone (5 shared papers)Joanne Savage (5 shared papers)
Journals
Journal of Hospital Infection (4 papers)European Journal of Biochemistry (3 papers)Biochemical Journal (2 papers)The Lancet Healthy Longevity (2 papers)PLoS ONE (2 papers)
Partner nations
United KingdomUnited StatesIreland

In The Last Decade

Christopher Fuller

35 papers receiving 1.4k citations

Peers

Christopher Fuller
Comparison fields: 5 of 123
  • Applied Microbiology and Biotechnology 78
  • Infectious Diseases 677
  • Clinical Biochemistry 125
  • Biochemistry 124
  • General Dentistry 18
Replace Young Hwa Choi with:
Young Hwa Choi South Korea
R. R. Kempker United States
Charles D. Wells United States
Peter D. O. Davies United Kingdom
Mary Ann Lansang Philippines
Mark Hull Canada
Vincent D. Marshall United States
De Chang China
Jason J. Schafer United States
Pui San Tan United Kingdom
Christopher Fuller relative to Young Hwa Choi South Korea Young Hwa Choi's profile →
Citations per field
00.5×5×10×13.8×
Young Hwa Choi · 1×
Citations per year

Countries citing papers authored by Christopher Fuller

Since Specialization
Citations

This map shows the geographic impact of Christopher Fuller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Fuller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Fuller more than expected).

Fields of papers citing papers by Christopher Fuller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Fuller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Fuller. The network helps show where Christopher Fuller may publish in the future.

Co-authors

The 25 scholars most cited alongside Christopher Fuller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christopher Fuller Line = papers co-authored together Christopher Fuller links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Evaluation of the national Cleanyourhands campaign to reduce Staphylococcus aureus bacteraemia and Clostridium difficile infection in hospitals in England and Wales by improved hand hygiene: four year, prospective, ecological, interrupted time series study
BMJ ·S. Stone, Christopher Fuller, Jeremy S. Savage, B. Cookson, Andrew C Hayward, Ben Symons Cooper, Georgia J Duckworth, Susan G. Michie, M. Murray, Annette Jeanes, Jennifer Roberts, L. Teare, André Charlett
2012188
2
“The Dirty Hand in the Latex Glove”: A Study of Hand Hygiene Compliance When Gloves Are Worn
Infection Control and Hospital Epidemiology ·Christopher Fuller, Joanne Savage, Sarah Jane Besser, Andrew C Hayward, B. Cookson, Ben Symons Cooper, Sheldon Stone
2011136
3
The Feedback Intervention Trial (FIT) — Improving Hand-Hygiene Compliance in UK Healthcare Workers: A Stepped Wedge Cluster Randomised Controlled Trial
PLoS ONE ·Christopher Fuller, Susan G. Michie, Joanne Savage, John McAteer, Sarah Jane Besser, André Charlett, Andrew C Hayward, B. Cookson, Ben Symons Cooper, Georgia J Duckworth, Annette Jeanes, (unknown), L. Teare, Sheldon Stone
2012131
4
Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study
The Lancet Infectious Diseases ·Madhumita Shrotri, Maria Krutikov, T Palmer, Rebecca Giddings, Borscha Azmi, Sathyavani Subbarao, Christopher Fuller, Aidan Irwin-Singer, Daniel Davies, Gokhan Tut, Jamie Lopez Bernal, P.L. Moss, Andrew C Hayward, Andrew J Copas, Laura J. Shallcross
2021118
5
Characterising an implementation intervention in terms of behaviour change techniques and theory: the ‘Sepsis Six’ clinical care bundle
Implementation Science ·Siri Steinmo, Christopher Fuller, Sheldon Paul Stone, Susan G. Michie
201583
6
Methicillin-resistant strains ofStaphylococcus aureus; presence of identical additional penicillin-binding protein in all strains examined
FEMS Microbiology Letters ·Peter E. Reynolds, Christopher Fuller
198683
7
Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibodies in staff and residents of long-term care facilities over the first year of the pandemic (VIVALDI study): prospective cohort study in England
The Lancet Healthy Longevity ·Maria Krutikov, T Palmer, Gokhan Tut, Christopher Fuller, Borscha Azmi, Rebecca Giddings, Madhumita Shrotri, Nayandeep Kaur, Panagiota Sylla, Tara Lancaster, Aidan Irwin-Singer, Andrew C Hayward, P.L. Moss, Andrew J Copas, Laura J. Shallcross
202177
8
Three-dimensional structure of the major autoantigen in primary biliary cirrhosis
Gastroenterology ·Mark J. Howard, Christopher Fuller, R. William Broadhurst, Richard Nelson Perham, Jian–Guo Tang, Janet Quinn, Austin G. Diamond, Stephen J. Yeaman
199868
9
Bridging the gap between pragmatic intervention design and theory: using behavioural science tools to modify an existing quality improvement programme to implement “Sepsis Six”
Implementation Science ·Siri Steinmo, Susan G. Michie, Christopher Fuller, Sarah R. Stanley, Caitriona Stapleton, Sheldon Paul Stone
201564
10
Autoantibodies in primary biliary cirrhosis: Analysis of reactivity against eukaryotic and prokaryotic 2-oxo acid dehydrogenase complexes
Hepatology ·Shelley P. M. Fussey, Gordon J. Lindsay, Christopher Fuller, Richard Nelson Perham, Susan J. Dale, Oliver James, Margaret F. Bassendine, Stephen J. Yeaman
199152
11
Selectivity of post-translational modification in biotinylated proteins: the carboxy carrier protein of the acetyl-CoA carboxylase of Escherichia coli
Biochemical Journal ·Pedro Antonio Reche, Yi-Li Li, Christopher Fuller, Knut Eichhorn, N. Richard PERHAM
199846
12
Development of an observational measure of healthcare worker hand-hygiene behaviour: the hand-hygiene observation tool (HHOT)
Journal of Hospital Infection ·John McAteer, S. Stone, Christopher Fuller, André Charlett, B. Cookson, Rachel Slade, Susan G. Michie, (unknown)
200846
13
Storytelling as a research tool and intervention around public health perceptions and behaviour: a protocol for a systematic narrative review
BMJ Open ·Becky McCall, Laura J. Shallcross, Michael Lowery Wilson, Christopher Fuller, Andrew C Hayward
201939
14
MCP-1 overexpressed in tuberous sclerosis lesions acts as a paracrine factor for tumor development
The Journal of Experimental Medicine ·Shaowei Li, Fumiko Takeuchi, Jianwu Wang, Christopher Fuller, Gustavo Pacheco–Rodriguez, Joel Moss, Thomas N. Darling
200538
15
Self‐assembly and catalytic activity of the pyruvate dehydrogenase multienzyme complex from Bacillus stearothermophilus
European Journal of Biochemistry ·Gonzalo J. Domingo, Hitesh J. Chauhan, Ivan A.D. Lessard, Christopher Fuller, Richard Nelson Perham
199937
16
Competitive Interaction of Component Enzymes with the Peripheral Subunit-Binding Domain of the Pyruvate Dehydrogenase Multienzyme Complex of Bacillus stearothermophilus: Kinetic Analysis Using Surface Plasmon Resonance Detection
Biochemistry ·Ivan A.D. Lessard, Christopher Fuller, Richard Nelson Perham
199630
17
The Role of Penicillin‐Binding Proteins in the Action of Cephalosporins against Escherichia coli and Salmonella typhimurium
European Journal of Biochemistry ·Howard A. Chase, Christopher Fuller, Peter E. Reynolds
198128
18
The peripheral subunit-binding domain of the dihydrolipoyl acetyltransferase component of the pyruvate dehydrogenase complex of Bacillus stearothermophilus: preparation and characterization of its binding to the dihydrolipoyl dehydrogenase component
Biochemical Journal ·Deborah S. Hipps, Leonard C. Packman, Mark D. Allen, Christopher Fuller, Kazuyasu Sakaguchi, Ettore Appella, Richard Nelson Perham
199426
19
Early communication: Does a national campaign to improve hand hygiene in the NHS work? Initial English and Welsh experience from the NOSEC study (National Observational Study to Evaluate the CleanYourHandsCampaign)
Journal of Hospital Infection ·S. Stone, Rachel Slade, Christopher Fuller, André Charlett, B. D. Cookson, L. Teare, Annette Jeanes, Ben Symons Cooper, Jennifer A. Roberts, Georgia J Duckworth, Andrew C Hayward, John McAteer, Susan G. Michie
200723
20
Duration of vaccine effectiveness against SARS-CoV-2 infection, hospitalisation, and death in residents and staff of long-term care facilities in England (VIVALDI): a prospective cohort study
The Lancet Healthy Longevity ·Madhumita Shrotri, Maria Krutikov, Hadjer Nacer-Laidi, Borscha Azmi, T Palmer, Rebecca Giddings, Christopher Fuller, Aidan Irwin-Singer, Verity Baynton, Gokhan Tut, P.L. Moss, Andrew C Hayward, Andrew J Copas, Laura J. Shallcross
202223

About Christopher Fuller

Christopher Fuller is a scholar working on Infectious Diseases, Clinical Biochemistry, Biochemistry, Applied Microbiology and Biotechnology and Molecular Medicine, having authored 35 papers that have together received 1.5k indexed citations. Recurring topics across this work include Infection Control in Healthcare (9 papers), Biochemical Acid Research Studies (6 papers), Metabolism and Genetic Disorders (4 papers), Antibiotic Use and Resistance (4 papers), Health Policy Implementation Science (3 papers), Biochemical and Molecular Research (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Antibiotic Resistance in Bacteria (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (78 citations), Infectious Diseases (677 citations), Clinical Biochemistry (125 citations), Biochemistry (124 citations) and General Dentistry (18 citations). Christopher Fuller has collaborated with scholars based in United Kingdom, United States and Ireland. Frequent co-authors include Susan G. Michie, Andrew C Hayward, B. Cookson, Peter E. Reynolds, Ben Symons Cooper, Richard Nelson Perham, Sheldon Stone, Joanne Savage, André Charlett and Sheldon Paul Stone. Their work appears in journals such as Journal of Hospital Infection, European Journal of Biochemistry, Biochemical Journal, The Lancet Healthy Longevity and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Young Hwa ChoiBreakdown of academic impact, for papers by R. R. KempkerBreakdown of academic impact, for papers by Charles D. WellsBreakdown of academic impact, for papers by Peter D. O. DaviesBreakdown of academic impact, for papers by Mary Ann LansangBreakdown of academic impact, for papers by Mark HullBreakdown of academic impact, for papers by Vincent D. MarshallBreakdown of academic impact, for papers by De ChangBreakdown of academic impact, for papers by Jason J. SchaferBreakdown of academic impact, for papers by Pui San Tan